Amit D. Munshi
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amit D. Munshi
Amit D. Munshi is recorded as Board Member at Arcutis Biotherapeutics, Inc. (ARQT). Arcutis Biotherapeutics, Inc. reported in an 8-K filed December 8, 2025 that Amit D. Munshi was appointed chair of the Compensation Committee of the Board, effective December 4, 2025. Arcutis Biotherapeutics, Inc. reported in an 8-K filed December 8, 2025 that Amit D. Munshi was appointed new Class II director, effective December 4, 2025.
“On December 4, 2025, the Board appointed Mr. Amit D. Munshi to the Board as a new Class II director and as the chair of the Compensation Committee of the Board.”
“On December 4, 2025, the Board appointed Mr. Amit D. Munshi to the Board as a new Class II director and as the chair of the Compensation Committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-12-04–present
-
Current
2025-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arcutis Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Todd Franklin Watanabe CEO, Board Member
- David Topper CFO, Chief Accounting Officer
- Latha Vairavan CFO
- Masaru Matsuda General Counsel
- Scott Burrows Chief Accounting Officer
- Chris Peetz Board Member
- Christopher Peetz Board Member
- Halley E. Gilbert Board Member
- Howard G. Welgus Board Member
- Howard Welgus, M.D., FAAD Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.